This medication is a gadolinium based contrast agent, prescribed for visualization of brain along with magnetic resonance imaging (MRI).  

Contraindicated in patients with hypersensitivity.

IV- The recommended dose is 0.2 mL/kg, (0.1 mmol/kg) as bolus injection.

It comes as a powder for injection (diluted with fluid) to be administered by a healthcare provider into the vein.

• Caution should be exercised in patients with history of acute kidney injury, impaired elimination of GBCAs, any allergy, who are taking other medications.

• Patient with impaired elimination of GBCAs may experience with increased risk of Nephrogenic Systemic Fibrosis.

• Monitor patients closely for need of emergency breathing support.

•  Most frequent: Nausea, headache, injection site pain, injection site coldness and burning sensation.
•  Heart: Abnormal heart rhythm, fast or slow heart rate.
•  Immune System: Hypersensitivity/anaphylactoid reactions including heart arrest, respiratory arrest, blue or purple coloration of the skin or mucous, throat swelling, asthma, eye inflammation, eyelid swelling, increased tears, increased sweating and hives.
•  Central Nervous System: Coma, convulsion, fainting, lightheadedness, smell loss, tremor
•  Musculoskeletal: Muscle contracture, muscle weakness.
•  Gastrointestinal: Diarrhea, increased salivary secretion.
•  General: Uneasiness and fever.
•  Skin: Inflammation of a vein

Avoid excess dosage.

Store it at controlled room temperature (25°C).